1040 - Growing Demand for Menopausal Hormone Therapies Brings Excitement—and New Concerns

1040 - Growing Demand for Menopausal Hormone Therapies Brings Excitement—and New Concerns

April 22, 2026 · 19 min · Season 13 · Episode 1040

About this episode

This episode discusses the surge in demand for menopausal hormone therapies following the FDA's regulatory changes and the associated concerns.

About this episode: Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions. Guests: Dr. Wendy L. Bennett , MPH, is a primary care doctor and associate professor with appointments at the Johns Hopkins Bloomberg School of Public Health and School of Medicine. Dr. Tina Zhang is a primary care doctor and assistant professor at the Johns Hopkins University School of Medicine. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs . Show links and related content: Why the 'mad scramble' to fill hormone therapy prescriptions for menopause —NPR FACT SHEET: FDA Initiates Removal of "Black Box" Warnings from Menopausal Hormone Replacement Therapy Products —U.S. Department of Health and Human Services What Is a Black Box Warning? —Johns Hopkins Bloomberg School of Public Health…

More episodes of Public Health On Call

Explore listener stats, chart rankings, contacts and more on the Public Health On Call podcast page.